Protagonist Therapeutics' Series A Round

Protagonist Therapeutics raised a round of funding on January 20, 2009.

Protagonist Therapeutics is a biotechnology company pursuing the discovery and development of target oral peptides as well differentiated alternatives to antibodies, and also as new chemical entities …

Articles about Protagonist Therapeutics' Series A Round: